Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Optic neuritis progressing to multiple sclerosis

T Corona-Vazquez1, J Ruiz-Sandoval, N Arriada-Mendicoa

  • 1Neurology Division, Instituto Nacional de Neurología, y Neurocirugía, Maxico City, Mexico.

Acta Neurologica Scandinavica
|February 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Perceived discrimination in patients with multiple sclerosis and depressive symptomatology.

Multiple sclerosis and related disorders·2020
Same author

Quality of life in patients with multiple sclerosis and its association with depressive symptoms and physical disability.

Multiple sclerosis and related disorders·2019
Same author

Pathological demonstration of cervical spinal cord inflammatory vasculitis in a patient with spontaneous spinal epidural haematoma associated with systemic lupus erythematosus.

Neuropathology and applied neurobiology·2010
Same author

[Pharmacogenomics: the quest for individualized therapy].

Revista de neurologia·2004
Same author

[Holospinal epidural haematoma following heart surgery].

Revista de neurologia·2003
Same author

Is it healthy to be chaotic?

Medical hypotheses·2003
Same journal

Editorial.

Acta neurologica Scandinavica·2022
Same journal

Advances in sudden unexpected death in epilepsy.

Acta neurologica Scandinavica·2022
Same journal

Non-convulsive seizures and non-convulsive status epilepticus in neuro-intensive care unit.

Acta neurologica Scandinavica·2022
Same journal

Positron emission tomography in autoimmune encephalitis: Clinical implications and future directions.

Acta neurologica Scandinavica·2022
Same journal

Seizure detection based on wearable devices: A review of device, mechanism, and algorithm.

Acta neurologica Scandinavica·2022
Same journal

Walking confidence and perceived locomotion ability explain participation after stroke: A cross-sectional experimental study.

Acta neurologica Scandinavica·2022
See all related articles

This study found that 12% of optic neuritis (ON) patients developed multiple sclerosis (MS) within two years. Laboratory and imaging results differed significantly between ON patients who developed MS and those who did not.

Area of Science:

  • Neuroscience
  • Ophthalmology
  • Immunology

Background:

  • Optic neuritis (ON) is an inflammatory condition of the optic nerve.
  • Multiple sclerosis (MS) is a chronic neurological disease affecting the central nervous system.
  • Differentiating ON patients who will develop MS is crucial for early intervention.

Purpose of the Study:

  • To identify clinical features and factors differentiating ON patients who develop MS from those who do not.
  • To determine the incidence of MS development in a cohort of ON patients.

Main Methods:

  • A partially retrospective and longitudinal study design was employed.
  • Clinical data, laboratory analyses (blood and CSF), MRI, and evoked potential studies were assessed.
  • Patients were categorized based on the origin of ON (idiopathic vs. secondary).

Related Experiment Videos

Main Results:

  • Of 110 idiopathic ON cases, 13 (12%) developed MS over an average of 2 years.
  • Laboratory results, MRI, and evoked potential studies showed significant differences in patients who developed MS.
  • The incidence of MS following ON in this cohort was relatively low compared to some previous reports.

Conclusions:

  • Specific clinical and diagnostic factors can help differentiate ON patients who progress to MS.
  • The observed rate of MS development after ON is comparable to findings in Japan.
  • Further research may refine predictive markers for MS development in ON patients.